Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy
about
Biomarkers to guide clinical therapeutics in rheumatology?Informatics-Based Discovery of Disease-Associated Immune Profiles.Immunocapture strategies in translational proteomics.Metabolic dysfunction and adipose tissue macrophages: is there more to glean from studying the lean?: Comment on "Adipose tissue infiltration in normal-weight subjects and its impact on metabolic function" by Moreno-Indias et al.Emerging Proteomic Technologies Provide Enormous and Underutilized Potential for Brain Cancer Research.Role of Immune Aging in Susceptibility to West Nile Virus.Deep Immune Profiling of an Arginine-Enriched Nutritional Intervention in Patients Undergoing Surgery.Mass Cytometry for Detection of Silver at the Bacterial Single Cell Level.High standards for high dimensional investigations.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.OMIP-034: Comprehensive immune phenotyping of human peripheral leukocytes by mass cytometry for monitoring immunomodulatory therapies.Silver nanoparticles for the detection of cell surface antigens in mass cytometry.
P2860
Q28080053-E9DCF193-1C39-46E9-970B-545E386E045EQ36144937-C3999200-29DF-4CDA-8EB6-881700E54176Q36519000-09B4A9B6-71FB-4F03-8A67-DE0087B2FAF7Q36900829-35C528E1-A8C0-429D-B12C-82AF6B064854Q38593065-777A31A9-D808-41CA-BA9F-F6CCBCA47F5BQ38836544-000C08D7-8FB1-4AEF-9DAC-CDA83C852E37Q40099659-3B862B5E-79CF-438E-AD5B-FA38EB8736B6Q41024183-2004C0E8-B221-467B-A7C4-4D8120C38830Q41761175-27F06B03-A7AA-4E01-A2D0-07764B494965Q41918189-F8BD2961-BFF3-4E71-8A38-0123BE09BD74Q50177437-FAC1962F-924B-4459-A293-71DE493BCEF4Q52850393-14EA66BA-4397-499F-AC28-824D602231C7Q53044556-2A9B358D-B3AE-4BD8-A35C-B815D4657085
P2860
Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@ast
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@en
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@nl
type
label
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@ast
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@en
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@nl
prefLabel
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@ast
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@en
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@nl
P2093
P2860
P921
P3181
P1476
Mass cytometry as a platform f ...... tive rheumatic disease therapy
@en
P2093
C Garrison Fathman
Chan C Whiting
Garry P Nolan
Henrik E Mei
Holden T Maecker
Mark Genovese
Matthew Hale
Shih-Yu Chen
P2860
P2888
P3181
P356
10.1186/S13075-015-0644-Z
P407
P50
P5008
P577
2015-05-18T00:00:00Z
P5875
P6179
1008953903